Semi-transparent solar cells are the next step for photovoltaics into our daily life. Over the last years, kesterite-type material has attracted a special attention to be used as an absorber in thin-film solar cells because of its low toxicity and earth abundant constituents. Here, Cu2ZnGeSe4 (CZGSe) thin films are grown by co-evaporation and subsequent annealing at a maximum temperature of 480 °C or 525 °C onto Mo/V2O5/FTO/glass stacks. The goal of this work is to investigate the influence of the annealing temperature on the composition, morphology, vibrational properties, and transmittance of CZGSe layers, the formation of secondary phases, and distribution of elements within the absorber layer as well as on the optoelectronic properties of the corresponding solar cell devices. Raising the annealing temperature to 525 °C leads to a more uniform distribution of Cu, Zn, Ge and Se throughout the absorber layer, a reduction of the presence of the GeSe2 secondary phase, which is mainly detected at 480 °C, a larger grain size and the formation of a thicker MoSe2 layer at the CZGSe/back contact interface. The strategy of increasing the annealing temperature allows for improved J–V characteristics and higher spectral response resulting in an enhanced device performance of 5.3% compared to 4.2% when using 525 °C and 480 °C, respectively. Both absorber layers present an optical band gap energy of 1.47 eV. Furthermore, higher annealing temperature has beneficial effect to the CZGSe-based devices without losses in total transmitted light because of the higher diffuse transmittance. This work shows first promising semi-transparent CZGSe-based solar cells possibly open up new routes of applications.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.